This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone quarter ended Sep 30, 2026: revenue Rs 14,863.64 lakh vs Rs 216.51 lakh a year earlier
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone Sep 2026 quarter: revenue from operations Rs 14,863.64 lakh vs Rs 216.51 lakh in the same quarter last year; profit after tax Rs 671.39 lakh vs Rs 659.73 lakh. Profit rose 1.8% as the year-ago quarter had a Rs 735 lakh extraordinary gain; sales jumped after the shift to IT and agricultural trading. The auditor qualified the review over cash-based employee benefits and noted the manufacturing shutdown. Earlier figures were regrouped.
The sales surge may support the stock, but the auditor qualification and dependence on a new trading model raise reporting and volatility risks.
The company's XBRL figures for this quarter look filed in the wrong unit: revenue reads ₹148.6 Cr against ₹2.17 Cr a year ago, about 69× larger. A move that size is almost always a wrong unit, not a business, so nothing is computed from these figures and no number-based tags are set; the read above is the AI's, from the document.